Cargando…
Characterization and Treatment Responsiveness of Genetically Engineered Ornithine Transcarbamylase-Deficient Pig
To develop novel medical technologies, pig disease models are invaluable especially in the final stages of translational research. Recently, we established a genetically engineered ornithine transcarbamylase-deficient (OTCD) pig strain. Here, we report its characterization and treatment responsivene...
Autores principales: | Enosawa, Shin, Hsu, Huai-Che, Yanagi, Yusuke, Matsunari, Hitomi, Uchikura, Ayuko, Nagashima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347267/ https://www.ncbi.nlm.nih.gov/pubmed/34362010 http://dx.doi.org/10.3390/jcm10153226 |
Ejemplares similares
-
Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency
por: Sugahara, Go, et al.
Publicado: (2020) -
Antepartum Ornithine Transcarbamylase Deficiency
por: Nakajima, Hitoshi, et al.
Publicado: (2014) -
Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency
por: Seker Yilmaz, Berna, et al.
Publicado: (2023) -
Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency
por: Li, Sitao, et al.
Publicado: (2018) -
Ornithine transcarbamylase deficiency: A diagnostic odyssey
por: Knerr, Ina, et al.
Publicado: (2022)